{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:07:02Z","timestamp":1789110422261,"version":"build-2803163510"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA258730"],"award-info":[{"award-number":["R37CA258730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1F31CA310315"],"award-info":[{"award-number":["1F31CA310315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA292949"],"award-info":[{"award-number":["R01CA292949"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA288820"],"award-info":[{"award-number":["R01CA288820"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["17YOUN12"],"award-info":[{"award-number":["17YOUN12"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["25CHAL05"],"award-info":[{"award-number":["25CHAL05"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218799","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:51:55Z","timestamp":1787669515000},"page":"218799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mirror worlds: The shared regulatory architecture of cell fate in development and cancer"],"prefix":"10.1016","volume":"659","author":[{"given":"Melanie","family":"Fraidenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Ghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Leapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Yi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-0896","authenticated-orcid":false,"given":"Ping","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1242\/dev.020867","article-title":"Epigenetic reprogramming and induced pluripotency","volume":"136","author":"Hochedlinger","year":"2009","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cell.2011.01.032","article-title":"Control of the embryonic stem cell state","volume":"144","author":"Young","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-026-06171-8","article-title":"Game of clones: decipher lineage plasticity in hormone-driven cancers","volume":"83","author":"Leonita","year":"2026","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2026.218799_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2026.150293","article-title":"Face\/off: phase-specific modeling of lineage plasticity using near-patient models in genitourinary cancers","volume":"1009","author":"Fu","year":"2026","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41422-025-01180-x","article-title":"Lineage plasticity and histological transformation: tumor histology as a spectrum","volume":"35","author":"Li","year":"2025","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41388-023-02890-5","article-title":"UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance","volume":"43","author":"Rodriguez Tirado","year":"2024","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.978","article-title":"The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy- and castration-resistant prostate cancer","volume":"12","author":"Lo","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ccell.2023.06.010","article-title":"Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib10","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/2159-8290.CD-23-0539","article-title":"ZNF397 deficiency triggers TET2-Driven lineage plasticity and AR-Targeted therapy resistance in prostate cancer","volume":"14","author":"Xu","year":"2024","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2020.06.012","article-title":"Emergence of a high-plasticity cell state during lung cancer evolution","volume":"38","author":"Marjanovic","year":"2020","journal-title":"Cancer Cell"},{"issue":"7567","key":"10.1016\/j.canlet.2026.218799_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature14669","article-title":"PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours","volume":"525","author":"Koren","year":"2015","journal-title":"Nature"},{"issue":"7658","key":"10.1016\/j.canlet.2026.218799_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature22794","article-title":"Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance","volume":"546","author":"Shaffer","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib14","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-13-3309","article-title":"Aggressive variants of castration-resistant prostate cancer","volume":"20","author":"Beltran","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41556-018-0236-7","article-title":"Tumour heterogeneity and metastasis at single-cell resolution","volume":"20","author":"Lawson","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.stem.2011.09.001","article-title":"Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice","volume":"9","author":"Arnold","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218799_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2001-1326-3-19","article-title":"SOX2 and cancer: current research and its implications in the clinic","volume":"3","author":"Weina","year":"2014","journal-title":"Clin. Transl. Med."},{"issue":"41","key":"10.1016\/j.canlet.2026.218799_bib18","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1073\/pnas.1410419111","article-title":"ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers","volume":"111","author":"Augustyn","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.canlet.2026.218799_bib19","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1038\/emboj.2011.340","article-title":"FOXA1: master of steroid receptor function in cancer","volume":"30","author":"Augello","year":"2011","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2026.218799_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","article-title":"Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance","volume":"3","author":"Deng","year":"2022","journal-title":"Nat. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.canlet.2026.218799_bib24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2008.002436","article-title":"The molecular biology of mixed lineage leukemia","volume":"94","author":"Slany","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1574888X1102160107171432","article-title":"BMI1 regulation of self-renewal and multipotency in human mesenchymal stem cells","volume":"11","author":"Jung","year":"2016","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2826","article-title":"The Hox genes and their roles in oncogenesis","volume":"10","author":"Shah","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/leu.2012.356","article-title":"The role of HOX genes in normal hematopoiesis and acute leukemia","volume":"27","author":"Alharbi","year":"2013","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"Emt: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7586","key":"10.1016\/j.canlet.2026.218799_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature17039","article-title":"Reparative inflammation takes charge of tissue regeneration","volume":"529","author":"Karin","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6320","key":"10.1016\/j.canlet.2026.218799_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.canlet.2026.218799_bib34","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","article-title":"Concurrent RB1 and TP53 alterations define a subset of EGFR-Mutant lung cancers at risk for histologic transformation and inferior clinical outcomes","volume":"14","author":"Offin","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib35","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.09.045","article-title":"Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome","volume":"151","author":"Soufi","year":"2012","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.canlet.2026.218799_bib36","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1158\/0008-5472.CAN-19-0585","article-title":"Banding together: a systematic comparison of the cancer genome Atlas and the mitelman databases","volume":"79","author":"Denomy","year":"2019","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/his.12176","article-title":"Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma","volume":"63","author":"Liu","year":"2013","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.stem.2012.12.007","article-title":"The sox family of transcription factors: versatile regulators of stem and progenitor cell fate","volume":"12","author":"Sarkar","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218799_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.606889","article-title":"Sorting sox: diverse roles for sox transcription factors during neural crest and craniofacial development","volume":"11","author":"Schock","year":"2020","journal-title":"Front. Physiol."},{"issue":"Pt 1","key":"10.1016\/j.canlet.2026.218799_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","article-title":"The role of SOX family members in solid tumours and metastasis","volume":"67","author":"Grimm","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41420-024-01834-6","article-title":"SOX on tumors, a comfort or a constraint?","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cr.2016.15","article-title":"Comprehensive profiling reveals mechanisms of SOX2-mediated cell fate specification in human ESCs and NPCs","volume":"26","author":"Zhou","year":"2016","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/scrt39","article-title":"Role of Oct4 in maintaining and regaining stem cell pluripotency","volume":"1","author":"Shi","year":"2010","journal-title":"Stem Cell Res. Ther."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1515\/hsz-2014-0317","article-title":"Overview of the roles of Sox2 in stem cell and development","volume":"396","author":"Feng","year":"2015","journal-title":"Biol. Chem."},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib45","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/14728222.2018.1538359","article-title":"Targeting SOX2 in anticancer therapy","volume":"22","author":"Huser","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","article-title":"SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond","volume":"39","author":"Schaefer","year":"2020","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jmcb\/mjy080","article-title":"SOX2 in cancer stemness: tumor malignancy and therapeutic potentials","volume":"12","author":"Mamun","year":"2020","journal-title":"J. Mol. Cell Biol."},{"issue":"45","key":"10.1016\/j.canlet.2026.218799_bib48","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1038\/s41388-018-0373-2","article-title":"Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma","volume":"37","author":"Ooki","year":"2018","journal-title":"Oncogene"},{"issue":"6320","key":"10.1016\/j.canlet.2026.218799_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib50","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41388-021-02157-x","article-title":"SOX2 mediates metabolic reprogramming of prostate cancer cells","volume":"41","author":"de Wet","year":"2022","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.gendis.2014.09.004","article-title":"The versatile functions of Sox9 in development, stem cells, and human diseases","volume":"1","author":"Jo","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.canlet.2026.218799_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6754040","article-title":"SOX9 stem-cell factor: clinical and functional relevance in cancer","volume":"2019","author":"Aguilar-Medina","year":"2019","journal-title":"J. Oncol."},{"issue":"23","key":"10.1016\/j.canlet.2026.218799_bib53","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1158\/0008-5472.CAN-15-3178","article-title":"Epigenetic switch between SOX2 and SOX9 regulates cancer cell plasticity","volume":"76","author":"Lin","year":"2016","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.canlet.2026.218799_bib54","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.18632\/oncotarget.24123","article-title":"SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition","volume":"9","author":"Francis","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jmedgenet-2021-108105","article-title":"SOX10: 20 years of phenotypic plurality and current understanding of its developmental function","volume":"59","author":"Pingault","year":"2022","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ydbio.2013.04.024","article-title":"The role of SOX10 during enteric nervous system development","volume":"382","author":"Bondurand","year":"2013","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1101\/gad.186601","article-title":"The transcription factor Sox10 is a key regulator of peripheral glial development","volume":"15","author":"Britsch","year":"2001","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.canlet.2026.218799_bib58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41419-021-04099-4","article-title":"SOX10 ablation severely impairs the generation of postmigratory neural crest from human pluripotent stem cells","volume":"12","author":"Lai","year":"2021","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.canlet.2026.218799_bib59","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1158\/0008-5472.CAN-12-4620","article-title":"SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis","volume":"73","author":"Cronin","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib60","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1038\/s44319-024-00258-8","article-title":"SOX10 mediates glioblastoma cell-state plasticity","volume":"25","author":"Man","year":"2024","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41523-022-00425-x","article-title":"Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer","volume":"8","author":"Saunus","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib62","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.celrep.2015.08.040","article-title":"Sox10 regulates Stem\/Progenitor and mesenchymal cell States in mammary epithelial cells","volume":"12","author":"Dravis","year":"2015","journal-title":"Cell Rep."},{"issue":"7044","key":"10.1016\/j.canlet.2026.218799_bib63","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature03649","article-title":"The initiation of liver development is dependent on Foxa transcription factors","volume":"435","author":"Lee","year":"2005","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib64","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1242\/dev.133900","article-title":"Cell fate control by pioneer transcription factors","volume":"143","author":"Iwafuchi-Doi","year":"2016","journal-title":"Development"},{"issue":"7","key":"10.1016\/j.canlet.2026.218799_bib65","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41580-022-00464-z","article-title":"Pioneer factors as master regulators of the epigenome and cell fate","volume":"23","author":"Balsalobre","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.730","article-title":"FOXA1 is a key determinant of estrogen receptor function and endocrine response","volume":"43","author":"Hurtado","year":"2011","journal-title":"Nat. Genet."},{"issue":"7765","key":"10.1016\/j.canlet.2026.218799_bib67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","article-title":"Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer","volume":"571","author":"Parolia","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib68","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1242\/dev.043299","article-title":"FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis","volume":"137","author":"Bernardo","year":"2010","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib69","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.stem.2017.08.008","article-title":"ASCL1 reorganizes chromatin to direct neuronal fate and suppress tumorigenicity of Glioblastoma Stem cells","volume":"21","author":"Park","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.canlet.2026.218799_bib70","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.stem.2022.09.006","article-title":"Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/mco.2016.1094","article-title":"Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients","volume":"6","author":"Wang","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib72","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/0008-5472.CAN-23-0438","article-title":"ASCL1 drives tolerance to osimertinib in EGFR mutant lung cancer in permissive cellular contexts","volume":"84","author":"Hu","year":"2024","journal-title":"Cancer Res."},{"issue":"11\u201312","key":"10.1016\/j.canlet.2026.218799_bib73","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1101\/gad.348295.121","article-title":"ASCL1 represses a SOX9(+) neural crest stem-like state in small cell lung cancer","volume":"35","author":"Olsen","year":"2021","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib74","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1164\/rccm.202110-2358OC","article-title":"Transcriptional circuitry of NKX2-1 and SOX1 defines an unrecognized lineage subtype of small-cell lung cancer","volume":"206","author":"Kong","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib75","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/s41467-022-29963-5","article-title":"ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer","volume":"13","author":"Nouruzi","year":"2022","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.canlet.2026.218799_bib76","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-24-1388","article-title":"Neuroendocrine differentiation in prostate cancer requires ASCL1","volume":"84","author":"Rodarte","year":"2024","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.canlet.2026.218799_bib77","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.185952","article-title":"ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer","volume":"9","author":"Nouruzi","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/CS20080068","article-title":"Thyroid transcription factor-1 (TTF-1\/Nkx2.1\/TITF1) gene regulation in the lung","volume":"116","author":"Boggaram","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib79","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000503683","article-title":"Haploinsufficiency of NKX2-1 in brain-lung-thyroid syndrome with additional multiple pituitary dysfunction","volume":"92","author":"Prasad","year":"2019","journal-title":"Horm. Res. Paediatr."},{"issue":"7171","key":"10.1016\/j.canlet.2026.218799_bib80","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nature06358","article-title":"Characterizing the cancer genome in lung adenocarcinoma","volume":"450","author":"Weir","year":"2007","journal-title":"Nature"},{"issue":"7345","key":"10.1016\/j.canlet.2026.218799_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature09881","article-title":"Suppression of lung adenocarcinoma progression by Nkx2-1","volume":"473","author":"Winslow","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib82","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.immuni.2018.09.020","article-title":"The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment","volume":"49","author":"Mollaoglu","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib83","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00439-020-02212-9","article-title":"Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease","volume":"140","author":"Thompson","year":"2021","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/gene.20008","article-title":"Tissue-specific expression of cre recombinase from the Pax8 locus","volume":"38","author":"Bouchard","year":"2004","journal-title":"Genesis"},{"issue":"22","key":"10.1016\/j.canlet.2026.218799_bib85","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1101\/gad.240102","article-title":"Nephric lineage specification by Pax2 and Pax8","volume":"16","author":"Bouchard","year":"2002","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib86","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ydbio.2006.11.016","article-title":"Pax2 regulates neuronal-glial cell fate choice in the embryonic optic nerve","volume":"303","author":"Soukkarieh","year":"2007","journal-title":"Dev. Biol."},{"issue":"18","key":"10.1016\/j.canlet.2026.218799_bib87","first-page":"4092","article-title":"Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides","volume":"55","author":"Gnarra","year":"1995","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1387\/ijdb.12141441","article-title":"PAX genes in development and disease: the role of PAX2 in urogenital tract development","volume":"46","author":"Eccles","year":"2002","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218799_bib89","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1146\/annurev.cellbio.23.090506.123438","article-title":"The role of pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions","volume":"23","author":"Buckingham","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib90","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1755-148X.2008.00514.x","article-title":"Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease","volume":"21","author":"Kubic","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib91","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrc1778","article-title":"A PANorama of PAX genes in cancer and development","volume":"6","author":"Robson","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib92","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/pcmr.13092","article-title":"Connecting the dots: melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance","volume":"36","author":"Castro-Perez","year":"2023","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib93","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1074-7613(02)00472-7","article-title":"Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1","volume":"17","author":"Souabni","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib94","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/leu.2015.140","article-title":"Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1","volume":"30","author":"Teo","year":"2016","journal-title":"Leukemia"},{"issue":"7137","key":"10.1016\/j.canlet.2026.218799_bib95","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib96","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1101\/gad.240416.114","article-title":"Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia","volume":"28","author":"Liu","year":"2014","journal-title":"Genes Dev."},{"issue":"57","key":"10.1016\/j.canlet.2026.218799_bib97","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1038\/sj.onc.1210056","article-title":"Diversity of LEF\/TCF action in development and disease","volume":"25","author":"Arce","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib98","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007906","article-title":"TCF\/LEFs and Wnt signaling in the nucleus","volume":"4","author":"Cadigan","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib99","first-page":"1685","article-title":"Differential expression and splicing isoform analysis of human Tcf-4 transcription factor in brain tumors","volume":"25","author":"Howng","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218799_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213488","article-title":"TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib101","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/j.gastro.2018.10.031","article-title":"TRIB3 interacts with beta-Catenin and TCF4 to increase stem cell features of colorectal cancer stem cells and tumorigenesis","volume":"156","author":"Hua","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib102","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.immuni.2012.08.009","article-title":"The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy","volume":"37","author":"Yu","year":"2012","journal-title":"Immunity"},{"issue":"16","key":"10.1016\/j.canlet.2026.218799_bib103","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.ejca.2009.08.003","article-title":"Targeting the WNT\/beta-catenin\/TCF\/LEF1 axis in solid and haematological cancers: multiplicity of therapeutic options","volume":"45","author":"Gehrke","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"47","key":"10.1016\/j.canlet.2026.218799_bib104","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1038\/onc.2015.85","article-title":"Lineage factors and differentiation states in lung cancer progression","volume":"34","author":"Cheung","year":"2015","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib105","first-page":"1389","article-title":"Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment","volume":"7","author":"Santiago","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"20","key":"10.1016\/j.canlet.2026.218799_bib106","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","article-title":"EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness","volume":"69","author":"Sanchez-Tillo","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib107","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbcan.2017.06.006","article-title":"EMT transcription factors in cancer development re-evaluated: beyond EMT and MET","volume":"1868","author":"Goossens","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib108","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4252\/wjsc.v5.i4.188","article-title":"Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer","volume":"5","author":"Garg","year":"2013","journal-title":"World J. Stem Cell."},{"issue":"14","key":"10.1016\/j.canlet.2026.218799_bib109","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1242\/dev.01907","article-title":"The Snail genes as inducers of cell movement and survival: implications in development and cancer","volume":"132","author":"Barrallo-Gimeno","year":"2005","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/35000025","article-title":"The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression","volume":"2","author":"Cano","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib111","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib112","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41556-018-0196-y","article-title":"Non-redundant functions of EMT transcription factors","volume":"21","author":"Stemmler","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib113","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4161\/19336918.2014.972740","article-title":"SLUG: critical regulator of epithelial cell identity in breast development and cancer","volume":"8","author":"Phillips","year":"2014","journal-title":"Cell Adh Migr"},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib114","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.stemcr.2014.03.008","article-title":"Cell-state transitions regulated by SLUG are critical for tissue regeneration and tumor initiation","volume":"2","author":"Phillips","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"19","key":"10.1016\/j.canlet.2026.218799_bib115","doi-asserted-by":"crossref","first-page":"17121","DOI":"10.18632\/oncotarget.2736","article-title":"SNAI2\/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression","volume":"6","author":"Esposito","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10555-021-10003-5","article-title":"Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance","volume":"41","author":"Garg","year":"2022","journal-title":"Cancer Metastasis Rev."},{"issue":"9","key":"10.1016\/j.canlet.2026.218799_bib117","doi-asserted-by":"crossref","first-page":"14783","DOI":"10.1002\/jcp.28277","article-title":"The crucial role of ZEB2: from development to epithelial-to-mesenchymal transition and cancer complexity","volume":"234","author":"Fardi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"20","key":"10.1016\/j.canlet.2026.218799_bib118","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1093\/nar\/gki965","article-title":"SIP1\/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions","volume":"33","author":"Vandewalle","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"21","key":"10.1016\/j.canlet.2026.218799_bib119","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1182\/blood-2010-08-300236","article-title":"The EMT regulator Zeb2\/Sip1 is essential for murine embryonic hematopoietic stem\/progenitor cell differentiation and mobilization","volume":"117","author":"Goossens","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/0008-5472.CAN-17-2476","article-title":"Pleiotropic roles for ZEB1 in cancer","volume":"78","author":"Caramel","year":"2018","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib121","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2741\/4893","article-title":"EMT imparts cancer stemness and plasticity: new perspectives and therapeutic potential","volume":"26","author":"Roy","year":"2021","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib122","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3892\/ijo_00000304","article-title":"Integrative genomic analyses of ZEB2: transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU\/OCT, and NF-kappaB","volume":"34","author":"Katoh","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib123","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ydbio.2008.03.037","article-title":"Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure","volume":"318","author":"Connerney","year":"2008","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003405","article-title":"Twist1 controls a cell-specification switch governing cell fate decisions within the cardiac neural crest","volume":"9","author":"Vincentz","year":"2013","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/onc.2016.286","article-title":"Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression","volume":"36","author":"Xu","year":"2017","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib126","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrg1726","article-title":"Modulating Hox gene functions during animal body patterning","volume":"6","author":"Pearson","year":"2005","journal-title":"Nat. Rev. Genet."},{"issue":"1\u20132","key":"10.1016\/j.canlet.2026.218799_bib127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1615\/CritRevOncog.v16.i1-2.70","article-title":"The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis","volume":"16","author":"Eklund","year":"2011","journal-title":"Crit. Rev. Oncog."},{"issue":"7","key":"10.1016\/j.canlet.2026.218799_bib128","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/ijc.30204","article-title":"The prognostic significance of specific HOX gene expression patterns in ovarian cancer","volume":"139","author":"Kelly","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218799_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218465","article-title":"HOX code-based stratification reveals RUNX1T1-HDAC reprogramming as a targetable driver of lineage plasticity across cancers","volume":"648","author":"Jiang","year":"2026","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ydbio.2005.10.032","article-title":"Hox cofactors in vertebrate development","volume":"291","author":"Moens","year":"2006","journal-title":"Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218799_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372873","article-title":"PBX1: a TALE of two seasons-key roles during development and in cancer","volume":"12","author":"Crisafulli","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib132","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.stemcr.2021.09.016","article-title":"PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm","volume":"16","author":"Muggeo","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib133","article-title":"PBX1 as a novel master regulator in cancer: its regulation, molecular biology, and therapeutic applications","volume":"1879","author":"Kao","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002368","article-title":"PBX1 genomic pioneer function drives ERalpha signaling underlying progression in breast cancer","volume":"7","author":"Magnani","year":"2011","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","article-title":"Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer","volume":"76","author":"Hamid","year":"2019","journal-title":"Eur. Urol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107669","article-title":"Combined TP53 and RB1 loss promotes prostate cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress","volume":"31","author":"Nyquist","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib137","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tig.2023.10.007","article-title":"Pioneer factors: roles and their regulation in development","volume":"40","author":"Barral","year":"2024","journal-title":"Trends Genet."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib138","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tig.2019.11.004","article-title":"The bivalent genome: characterization, structure, and regulation","volume":"36","author":"Blanco","year":"2020","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib139","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST20230426","article-title":"Bivalent chromatin: a developmental balancing act tipped in cancer","volume":"52","author":"Glancy","year":"2024","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib140","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500447","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics","volume":"1","author":"Kadoch","year":"2015","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.canlet.2026.218799_bib141","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib142","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1038\/s41467-018-06656-6","article-title":"SWI\/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib143","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ng.3744","article-title":"ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice","volume":"49","author":"Mathur","year":"2017","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib144","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1038\/s41467-020-19328-1","article-title":"Role of specialized composition of SWI\/SNF complexes in prostate cancer lineage plasticity","volume":"11","author":"Cyrta","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218799_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108610","article-title":"The therapeutic potential of targeting the CHD protein family in cancer","volume":"256","author":"Zhang","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2026.218799_bib146","article-title":"Advances in Chromodomain Helicase DNA-Binding (CHD) proteins regulating stem cell differentiation and human diseases","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib147","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13046-025-03428-1","article-title":"CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential","volume":"44","author":"Clune","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib148","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","article-title":"Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-Targeted therapy via chromatin dysregulation","volume":"37","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib149","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1471-4159.2001.00324.x","article-title":"Cloning and characterization of the murine Imitation Switch (ISWI) genes: differential expression patterns suggest distinct developmental roles for Snf2h and Snf2l","volume":"77","author":"Lazzaro","year":"2001","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.canlet.2026.218799_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000241","article-title":"Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells","volume":"4","author":"Landry","year":"2008","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib151","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2012.08.030","article-title":"Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells","volume":"48","author":"Lin","year":"2012","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib152","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/stem.1879","article-title":"The combination of Tet1 with Oct4 generates high-quality mouse-induced pluripotent stem cells","volume":"33","author":"Chen","year":"2015","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2026.218799_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110593","article-title":"GATA6 triggers fibroblast activation and tracheal fibrosis through the Wnt\/beta-catenin pathway","volume":"105","author":"Li","year":"2023","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib154","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3892\/or.2013.2544","article-title":"GATA6 predicts prognosis and hepatic metastasis of colorectal cancer","volume":"30","author":"Shen","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2026.218799_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108334","article-title":"DNA methylation in cell plasticity and malignant transformation in liver diseases","volume":"241","author":"Kim","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"13","key":"10.1016\/j.canlet.2026.218799_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133325","article-title":"Chromatin and epigenetic dysregulation of prostate cancer development, progression, and therapeutic response","volume":"13","author":"Kukkonen","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7010","key":"10.1016\/j.canlet.2026.218799_bib157","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nature02985","article-title":"Role of histone H2A ubiquitination in Polycomb silencing","volume":"431","author":"Wang","year":"2004","journal-title":"Nature"},{"issue":"13\u201314","key":"10.1016\/j.canlet.2026.218799_bib158","first-page":"675","article-title":"Hyd\/UBR5 defines a tumor suppressor pathway that links Polycomb repressive complex to regulated protein degradation in tissue growth control and tumorigenesis","volume":"38","author":"Wen","year":"2024","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib159","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molcel.2005.12.002","article-title":"Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing","volume":"20","author":"Cao","year":"2005","journal-title":"Mol. Cell"},{"issue":"6937","key":"10.1016\/j.canlet.2026.218799_bib160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","article-title":"Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells","volume":"423","author":"Park","year":"2003","journal-title":"Nature"},{"issue":"6961","key":"10.1016\/j.canlet.2026.218799_bib161","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/nature02060","article-title":"Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation","volume":"425","author":"Molofsky","year":"2003","journal-title":"Nature"},{"issue":"6715","key":"10.1016\/j.canlet.2026.218799_bib162","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/16476","article-title":"The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus","volume":"397","author":"Jacobs","year":"1999","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.canlet.2026.218799_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158231","article-title":"The crucial roles of Bmi-1 in cancer: implications in pathogenesis, metastasis, drug resistance, and targeted therapies","volume":"23","author":"Xu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib164","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70566","article-title":"Insights into the role of Bmi-1 deregulation in promoting stemness and therapy resistance in glioblastoma: a narrative review","volume":"14","author":"Shaalan","year":"2025","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41467-018-02863-3","article-title":"BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218799_bib166","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1186\/1471-2407-14-785","article-title":"Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog","volume":"14","author":"Paranjape","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib167","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","article-title":"Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes","volume":"15","author":"Venkadakrishnan","year":"2024","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.canlet.2026.218799_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17193111","article-title":"EZH2 dysregulation and its oncogenic role in human cancers","volume":"17","author":"Verma","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.canlet.2026.218799_bib169","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","article-title":"Chromatin remodellers as therapeutic targets","volume":"23","author":"Malone","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.canlet.2026.218799_bib170","first-page":"443","article-title":"DNA methylation dynamics in cellular commitment and differentiation","volume":"15","author":"Suelves","year":"2016","journal-title":"Brief. Funct. Genom."},{"issue":"5","key":"10.1016\/j.canlet.2026.218799_bib171","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4161\/epi.28324","article-title":"The de novo DNA methyltransferase DNMT3A in development and cancer","volume":"9","author":"Chen","year":"2014","journal-title":"Epigenetics"},{"issue":"19","key":"10.1016\/j.canlet.2026.218799_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38663","article-title":"The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC)","volume":"10","author":"Mohd Kamal","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib173","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.trecan.2025.12.004","article-title":"Exploiting tumor lineage features for precision cancer therapy","volume":"12","author":"Kelly","year":"2026","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218799_bib174","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.01.019","article-title":"Profiling of human epigenetic regulators using a semi-automated real-time qPCR platform validated by next generation sequencing","volume":"609","author":"Dudakovic","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2026.218799_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2025.1612181","article-title":"Circulating tumor cells: indicators of cancer progression, plasticity and utility for therapies","volume":"31","author":"Linkner","year":"2025","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib176","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/ERC-19-0420","article-title":"The epigenetic and transcriptional landscape of neuroendocrine prostate cancer","volume":"27","author":"Davies","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib177","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.annonc.2020.02.002","article-title":"Epigenetic modulations and lineage plasticity in advanced prostate cancer","volume":"31","author":"Ge","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218799_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1744018","article-title":"The role of epigenetic modifications in hematological cancers","volume":"16","author":"Ilic","year":"2026","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib179","first-page":"277","article-title":"The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy","volume":"2","author":"Yang","year":"2022","journal-title":"J. Natl. Cancer Cent."},{"issue":"7","key":"10.1016\/j.canlet.2026.218799_bib180","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev."},{"issue":"23","key":"10.1016\/j.canlet.2026.218799_bib181","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1101\/gad.179184.111","article-title":"Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation","volume":"25","author":"Wu","year":"2011","journal-title":"Genes Dev."},{"issue":"7325","key":"10.1016\/j.canlet.2026.218799_bib182","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature09586","article-title":"Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2","volume":"468","author":"Ko","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib183","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218799_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.926585","article-title":"The role of epigenetic change in therapy-induced neuroendocrine prostate cancer lineage plasticity","volume":"13","author":"Storck","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"722","key":"10.1016\/j.canlet.2026.218799_bib185","doi-asserted-by":"crossref","first-page":"eadf6732","DOI":"10.1126\/scitranslmed.adf6732","article-title":"Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer","volume":"15","author":"Yamada","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib186","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12860-025-00552-w","article-title":"Evolutionary and structural insights into DNMTs and TETs: decoding their functional heterogeneity and oncogenic roles in methylation regulation","volume":"26","author":"Yang","year":"2025","journal-title":"BMC Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib187","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.celrep.2014.08.071","article-title":"5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex","volume":"9","author":"Takai","year":"2014","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib188","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/MCB.20.4.1394-1406.2000","article-title":"Active repression of methylated genes by the chromosomal protein MBD1","volume":"20","author":"Ng","year":"2000","journal-title":"Mol. Cell Biol."},{"issue":"15","key":"10.1016\/j.canlet.2026.218799_bib189","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1101\/gad.13.15.1924","article-title":"Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation","volume":"13","author":"Zhang","year":"1999","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.canlet.2026.218799_bib190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ncb1372","article-title":"The NuRD component Mbd3 is required for pluripotency of embryonic stem cells","volume":"8","author":"Kaji","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218799_bib191","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1128\/MCB.18.11.6538","article-title":"Identification and characterization of a family of mammalian methyl-CpG binding proteins","volume":"18","author":"Hendrich","year":"1998","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib192","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/15384047.2018.1450113","article-title":"Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells","volume":"19","author":"Cheng","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib193","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/mmr.2016.5404","article-title":"MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.canlet.2026.218799_bib194","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/1566524016666160316154150","article-title":"MBD1 is an epigenetic regulator of KEAP1 in pancreatic cancer","volume":"16","author":"Zhang","year":"2016","journal-title":"Curr. Mol. Med."},{"issue":"19","key":"10.1016\/j.canlet.2026.218799_bib195","doi-asserted-by":"crossref","DOI":"10.3390\/cells12192392","article-title":"Aging and age-related epigenetic drift in the pathogenesis of leukemia and lymphomas: new therapeutic targets","volume":"12","author":"Allegra","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.canlet.2026.218799_bib196","doi-asserted-by":"crossref","DOI":"10.3390\/epigenomes10020027","article-title":"Age-Related epigenetic drift shapes coordinated microRNA promoter methylation and expression in prostate cancer","volume":"10","author":"Bergez-Hernandez","year":"2026","journal-title":"Epigenomes"},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib197","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2217\/epi-2016-0078","article-title":"Age-related epigenetic drift and phenotypic plasticity loss: implications in prevention of age-related human diseases","volume":"8","author":"Li","year":"2016","journal-title":"Epigenomics"},{"issue":"17","key":"10.1016\/j.canlet.2026.218799_bib198","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172800","article-title":"A polyomavirus-positive merkel cell Carcinoma Mouse model supports a unified origin for somatic and germ cell cancers","volume":"17","author":"Yang","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib199","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-025-02369-9","article-title":"Current AI technologies in cancer diagnostics and treatment","volume":"24","author":"Tiwari","year":"2025","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218799_bib200","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41592-024-02408-1","article-title":"Mapping cellular interactions from spatially resolved transcriptomics data","volume":"21","author":"Zhu","year":"2024","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib201","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-025-02321-x","article-title":"Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges","volume":"24","author":"Mao","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13073-024-01309-4","article-title":"Deciphering cancer cell state plasticity with single-cell genomics and artificial intelligence","volume":"16","author":"Holton","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2026.218799_bib203","article-title":"Deep learning models for cancer stem cell detection: a brief review","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.canlet.2026.218799_bib204","doi-asserted-by":"crossref","DOI":"10.3390\/cells15080700","article-title":"Integrative computational approaches to prostate cancer with conditional reprogramming and AI-Driven precision medicine","volume":"15","author":"Fadiel","year":"2026","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.canlet.2026.218799_bib205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s41065-025-00564-8","article-title":"Cancer cell plasticity and therapeutic resistance: mechanisms, crosstalk, and translational perspectives","volume":"162","author":"Ghorbian","year":"2025","journal-title":"Hereditas"},{"issue":"12","key":"10.1016\/j.canlet.2026.218799_bib206","article-title":"The redox-adhesion-exosome (RAX) hub in cancer: lipid peroxidation-driven EMT plasticity and ferroptosis defense with HNE\/MDA signaling and lipidomic perspectives","volume":"14","author":"Park","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.canlet.2026.218799_bib207","article-title":"Mechanisms and technologies in cancer epigenetics","volume":"14","author":"Sherif","year":"2024","journal-title":"Front. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600563X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600563X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:34:12Z","timestamp":1789108452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352600563X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":207,"alternative-id":["S030438352600563X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218799","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mirror worlds: The shared regulatory architecture of cell fate in development and cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218799"}}